Moderna, Inc. (MRNA)
USD 24.19
(-3.68%)
USD 24.19
(-3.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.28 Billion USD | -137.04% |
| 2022 | 9.76 Billion USD | -26.53% |
| 2021 | 13.52 Billion USD | 1842.27% |
| 2020 | -732 Million USD | -39.84% |
| 2019 | -515 Million USD | -32.05% |
| 2018 | -388.4 Million USD | -66.09% |
| 2017 | -235.32 Million USD | -19.25% |
| 2016 | -208.65 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.23 Billion USD | -639.9% |
| 2024 Q2 | -1.32 Billion USD | -9.71% |
| 2023 Q4 | 208 Million USD | 111.8% |
| 2023 FY | - USD | -132.87% |
| 2023 Q2 | -1.77 Billion USD | -516.32% |
| 2023 Q3 | -1.76 Billion USD | 0.68% |
| 2023 Q1 | -288 Million USD | -117.35% |
| 2022 Q2 | 2.44 Billion USD | -43.36% |
| 2022 Q4 | 1.58 Billion USD | 17.73% |
| 2022 FY | - USD | -26.53% |
| 2022 Q1 | 4.32 Billion USD | -20.15% |
| 2022 Q3 | 1.34 Billion USD | -45.16% |
| 2021 Q1 | 1.27 Billion USD | 564.66% |
| 2021 FY | - USD | 1842.27% |
| 2021 Q4 | 5.41 Billion USD | 49.2% |
| 2021 Q3 | 3.62 Billion USD | 15.66% |
| 2021 Q2 | 3.13 Billion USD | 145.31% |
| 2020 FY | - USD | -39.84% |
| 2020 Q3 | -235.11 Million USD | -92.52% |
| 2020 Q4 | -275.03 Million USD | -16.98% |
| 2020 Q1 | -115.37 Million USD | 11.63% |
| 2020 Q2 | -122.12 Million USD | -5.86% |
| 2019 Q1 | -141.83 Million USD | 7.32% |
| 2019 Q4 | -130.55 Million USD | -13.88% |
| 2019 Q3 | -114.64 Million USD | 20.35% |
| 2019 Q2 | -143.93 Million USD | -1.48% |
| 2019 FY | - USD | -32.05% |
| 2018 Q3 | -73.1 Million USD | 14.07% |
| 2018 Q1 | -67.25 Million USD | -87.27% |
| 2018 FY | - USD | -66.09% |
| 2018 Q4 | -153.03 Million USD | -109.34% |
| 2018 Q2 | -85.07 Million USD | -26.5% |
| 2017 Q4 | -35.91 Million USD | 42.76% |
| 2017 Q3 | -62.74 Million USD | 16.44% |
| 2017 Q2 | -75.08 Million USD | 0.0% |
| 2017 Q1 | -75.08 Million USD | 0.0% |
| 2017 FY | - USD | -19.25% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -1608.49% |
| Alkermes plc | 495.04 Million USD | 763.167% |
| Agenus Inc. | -145.92 Million USD | -2149.801% |
| Aptorum Group Limited | -9.59 Million USD | -34101.49% |
| Ardelyx, Inc. | -55.35 Million USD | -5830.917% |
| Dyadic International, Inc. | -8.22 Million USD | -39791.909% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -1128078.694% |
| Lantern Pharma Inc. | -15.78 Million USD | -20696.001% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -16387.219% |
| Novavax, Inc. | -487.39 Million USD | -573.588% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -4522.381% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -4082.539% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -18165.831% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -32835.393% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -5621.911% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -764.018% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -13515.684% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 620704.915% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -1988.489% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -4288.165% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -16185.53% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -13731.894% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -14138.009% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -2588.714% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -1171.288% |
| AlloVir, Inc. | -190.14 Million USD | -1626.568% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -1768.824% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -11120.863% |
| Bicycle Therapeutics plc | -183.4 Million USD | -1690.076% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -1884.633% |
| ChromaDex Corporation | -3.89 Million USD | -84209.194% |
| Chimerix, Inc. | -92.97 Million USD | -3431.095% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -7288.037% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -2817.341% |
| CRISPR Therapeutics AG | -202.7 Million USD | -1519.627% |
| Precision BioSciences, Inc. | -32.04 Million USD | -10145.927% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -1806.183% |
| Fortress Biotech, Inc. | -133.64 Million USD | -2356.545% |
| Fortress Biotech, Inc. | -133.64 Million USD | -2356.545% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -4144.728% |
| ImmuCell Corporation | -2.5 Million USD | -131006.192% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -2417.233% |
| Immix Biopharma, Inc. | -16.13 Million USD | -20246.258% |
| Incyte Corporation | 919.42 Million USD | 457.071% |
| Innoviva, Inc. | 248.96 Million USD | 1418.686% |
| IO Biotech, Inc. | -91.22 Million USD | -3498.676% |
| Jaguar Health, Inc. | -33.13 Million USD | -9809.149% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -2057.356% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 3327.265% |
| ContextLogic Inc. | -324 Million USD | -913.272% |
| MiMedx Group, Inc. | 40.51 Million USD | 8202.772% |
| MEI Pharma, Inc. | 26.38 Million USD | 12545.034% |
| NextCure, Inc. | -59.03 Million USD | -5460.731% |
| Onconetix, Inc. | -36.7 Million USD | -8843.865% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 146990.38% |
| Opthea Limited | -200.01 Million USD | -1541.346% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -119213.267% |
| Vaxcyte, Inc. | -464.88 Million USD | -606.196% |
| PDS Biotechnology Corporation | -40.08 Million USD | -8090.102% |
| Precigen, Inc. | -89.22 Million USD | -3579.421% |
| Pharming Group N.V. | 9.87 Million USD | 33338.838% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -1964.144% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -14323.161% |
| PureTech Health plc | -11.62 Million USD | -28136.002% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -19233.373% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -1306.014% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -13515.684% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -3655.133% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -11235.152% |
| Acelyrin, Inc. | -381.52 Million USD | -760.492% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -25479356.945% |
| Summit Therapeutics Inc. | 1 Million USD | 328072.028% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -9733.463% |
| Senti Biosciences, Inc. | -61.33 Million USD | -5252.485% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -2823.315% |
| Elevation Oncology, Inc. | -41.46 Million USD | -7817.139% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -10523.22% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -53574.083% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -1022641.433% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -10016.168% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -39001.953% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -5484.283% |
| Seer, Inc. | -97.88 Million USD | -3253.936% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -5178.39% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -4922.566% |
| ESSA Pharma Inc. | -26.45 Million USD | -12309.607% |
| GlycoMimetics, Inc. | -39.12 Million USD | -8291.699% |
| GT Biopharma, Inc. | 5.97 Million USD | 55008.848% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -1488.346% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -47701.398% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 3881.735% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -5684.614% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -6309.731% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -33105.538% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | -508.044% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -47590.296% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -6905.676% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -1287.445% |
| Aptose Biosciences Inc. | -52.26 Million USD | -6181.09% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -2947.055% |
| Soligenix, Inc. | -7.85 Million USD | -41706.478% |
| Century Therapeutics, Inc. | -121.2 Million USD | -2608.567% |
| Kura Oncology, Inc. | -164.95 Million USD | -1890.24% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -3998.729% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -32450.069% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -342686.5% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -76089.371% |
| Autolus Therapeutics plc | -156.77 Million USD | -1994.151% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -3778.002% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -4657.902% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -16369.349% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -1634.532% |
| GRI Bio, Inc. | -10.89 Million USD | -30024.794% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -72601.665% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -2579.869% |
| IGM Biosciences, Inc. | -253.35 Million USD | -1195.795% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -3063.057% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -8509.292% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -21314.258% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -20753.392% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -5675.354% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -2965.274% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -1134.224% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -1592.8% |
| Verastem, Inc. | -83.16 Million USD | -3847.527% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -6391.735% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -1974.854% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -2777.578% |
| Histogen Inc. | -10.5 Million USD | -31157.736% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -22890.666% |
| Surrozen, Inc. | -41.13 Million USD | -7881.814% |
| Organovo Holdings, Inc. | -14.8 Million USD | -22073.443% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 102369916.027% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -5491.589% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -6300.359% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -15142.119% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -39273.927% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -1876.922% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -6564.844% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -13485.202% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -21706.652% |
| Apollomics, Inc. | -171.74 Million USD | -1811.533% |
| Amarin Corporation plc | -50.9 Million USD | -6349.708% |
| Mesoblast Limited | -61.33 Million USD | -5252.921% |
| Turnstone Biologics Corp. | -56.23 Million USD | -5738.105% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -2192.582% |
| Synaptogenix, Inc. | -8.3 Million USD | -39418.474% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -21302.96% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -5107.226% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -68417.652% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 765298.502% |
| Exelixis, Inc. | 196.6 Million USD | 1769.871% |
| Better Therapeutics, Inc. | -38.26 Million USD | -8480.315% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -2221.634% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -562.95% |
| NLS Pharmaceutics AG | -11.79 Million USD | -27732.282% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 1328088.48% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -11026.551% |
| Gritstone bio, Inc. | -126.86 Million USD | -2487.831% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -4951.935% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -81976.108% |
| Avid Bioservices, Inc. | -11.48 Million USD | -28495.07% |
| Insmed Incorporated | -654.73 Million USD | -401.421% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -145829.336% |
| MediWound Ltd. | -4.89 Million USD | -66995.851% |
| OmniAb, Inc. | -49.73 Million USD | -6501.516% |
| Alector, Inc. | -142.89 Million USD | -2197.539% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -3742.732% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -6195.543% |
| Zai Lab Limited | -366.57 Million USD | -795.592% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -1029.588% |
| Aura Biosciences, Inc. | -83.69 Million USD | -3822.529% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -1357.498% |
| Immunic, Inc. | -99.11 Million USD | -3212.414% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -2393.355% |
| Veracyte, Inc. | -49.4 Million USD | -6544.538% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -46375.539% |
| FibroGen, Inc. | -261.4 Million USD | -1155.906% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -29367.732% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -46791.104% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -17440.329% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 326.504% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -12814.011% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 8330.133% |
| TG Therapeutics, Inc. | 26.1 Million USD | 12678.544% |
| Galecto, Inc. | -37.51 Million USD | -8650.233% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -8479.642% |
| Fortrea Holdings Inc. | 167.3 Million USD | 2062.343% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -2344.891% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -11496.199% |
| XBiotech Inc. | -35.76 Million USD | -9079.109% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -4951.935% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -4931.418% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -3042.98% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -12688.252% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -7933.377% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -535.681% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -5760.302% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -5857065.795% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -2722.023% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -14708.597% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -1296.641% |
| NexImmune, Inc. | -28.16 Million USD | -11555.272% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -59314.921% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -27740.267% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 170.538% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -12829.269% |
| Scopus BioPharma Inc. | -11.71 Million USD | -27928.33% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -2508.744% |
| Ainos, Inc. | -8.77 Million USD | -37321.217% |
| Pluri Inc. | -20.22 Million USD | -16132.386% |
| Prothena Corporation plc | -190.1 Million USD | -1626.913% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -2460.882% |
| Celularity Inc. | -183.94 Million USD | -1684.763% |
| Rallybio Corporation | -72.37 Million USD | -4436.222% |
| Cue Biopharma, Inc. | -46.05 Million USD | -7028.898% |
| MeiraGTx Holdings plc | -57.05 Million USD | -5654.399% |
| Omeros Corporation | -163.61 Million USD | -1906.601% |
| Humacyte, Inc. | -96.45 Million USD | -3303.554% |
| Immunocore Holdings plc | -59.64 Million USD | -5403.864% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -16847.14% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -13374.246% |
| Blueprint Medicines Corporation | -474.61 Million USD | -591.723% |
| CalciMedica, Inc. | -34.18 Million USD | -9502.504% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -4382.89% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -2515.999% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -1848.935% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -1200.765% |
| Pulmatrix, Inc. | -12.64 Million USD | -25860.778% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -9858.745% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -3610.988% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -548.411% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -3143.59% |
| Cytokinetics, Incorporated | -456.68 Million USD | -618.878% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -9737.294% |
| Nutriband Inc. | -5.12 Million USD | -63998.847% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -7486.892% |
| Vor Biopharma Inc. | -114.37 Million USD | -2770.483% |
| Roivant Sciences Ltd. | -996.51 Million USD | -229.448% |
| Evogene Ltd. | -23.2 Million USD | -14048.423% |
| ProKidney Corp. | -147.66 Million USD | -2123.215% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -4987.162% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -2143564.013% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | -480.581% |
| CorMedix Inc. | -48.88 Million USD | -6615.482% |
| BioLineRx Ltd. | -57.06 Million USD | -5653.492% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -2837.597% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -1625147.525% |
| Atai Life Sciences N.V. | -36.31 Million USD | -8941.337% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -4028.677% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -3937.485% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -1091.639% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -10579.896% |
| MediciNova, Inc. | -9.87 Million USD | -33128.846% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -2506.776% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -214446.978% |
| GeoVax Labs, Inc. | -26.66 Million USD | -12210.279% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -1359.169% |
| Biomea Fusion, Inc. | -124.62 Million USD | -2534.409% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -893.825% |
| Mereo BioPharma Group plc | -26.05 Million USD | -12499.785% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -1624.817% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -1327.751% |
| Absci Corporation | -95.45 Million USD | -3339.245% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -10834.221% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -2964.844% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -1306.14% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -14264.472% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -1479.611% |
| Allakos Inc. | -189.91 Million USD | -1628.668% |
| Imunon, Inc. | -19.87 Million USD | -16415.514% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -2926.03% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 3130.723% |
| BioAtla, Inc. | -122.24 Million USD | -2585.678% |
| NLS Pharmaceutics AG | -11.79 Million USD | -27732.282% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -20729.897% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -993.266% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -7820.959% |
| XOMA Corporation | -39.36 Million USD | -8240.531% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -3207.675% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -2690.48% |
| aTyr Pharma, Inc. | -52.17 Million USD | -6191.924% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -3816.96% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -2108.826% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -1299.612% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -23945.997% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -40721.655% |
| Akari Therapeutics, Plc | -16.8 Million USD | -19439.341% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 1739843.304% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 826.413% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -51288.21% |
| UroGen Pharma Ltd. | -63.83 Million USD | -5043.269% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -4733.984% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -45101.633% |
| Orgenesis Inc. | -60.71 Million USD | -5306.963% |
| Entera Bio Ltd. | -8.8 Million USD | -37189.868% |
| GH Research PLC | -41.15 Million USD | -7877.547% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -12764.924% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -3892.315% |
| Xencor, Inc. | -125.87 Million USD | -2508.164% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -230036.449% |
| Replimune Group, Inc. | -230.19 Million USD | -1326.164% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -16186.647% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -29903.656% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -51288.21% |
| Portage Biotech Inc. | -18.19 Million USD | -17939.453% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -214446.978% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -3039.103% |
| OncoCyte Corporation | -23.12 Million USD | -14097.985% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -28952.167% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -28555.373% |
| Purple Biotech Ltd. | -22.22 Million USD | -14671.654% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -51116.849% |
| scPharmaceuticals Inc. | -46.06 Million USD | -7027.505% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -18333.793% |
| HilleVax, Inc. | -132.46 Million USD | -2378.372% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -30775.576% |
| Tharimmune, Inc. | -9.3 Million USD | -35191.251% |
| Genprex, Inc. | -31.06 Million USD | -10469.672% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -1650.691% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -10370.753% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -429612.042% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 2175655.32% |
| OKYO Pharma Limited | -15.74 Thousand USD | -20849811.755% |
| Savara Inc. | -59.13 Million USD | -5451.891% |
| Curis, Inc. | -45.13 Million USD | -7173.09% |
| Daré Bioscience, Inc. | -30.7 Million USD | -10593.283% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -21511.27% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -45719.958% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -12180.242% |
| BeiGene, Ltd. | -1.12 Billion USD | -191.923% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -20039.622% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -662.456% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -3534.049% |
| Erasca, Inc. | -121.31 Million USD | -2606.29% |
| bluebird bio, Inc. | -167.16 Million USD | -1863.975% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -72875.729% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 1158.063% |
| DBV Technologies S.A. | -85.98 Million USD | -3718.241% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -72875.729% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -7604.945% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -58026.771% |
| Molecular Templates, Inc. | 1.43 Million USD | 229680.42% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -5385.197% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -906.296% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -2294.795% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -6831.132% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -2261.293% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -1494.773% |
| MacroGenics, Inc. | 2.01 Million USD | 162866.485% |
| RenovoRx, Inc. | -11.39 Million USD | -28723.529% |
| Adicet Bio, Inc. | -136.53 Million USD | -2304.512% |
| Prime Medicine, Inc. | -193.75 Million USD | -1594.373% |
| Aditxt, Inc. | -25.45 Million USD | -12795.768% |
| Adagene Inc. | -14.95 Million USD | -21858.713% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -44810.479% |
| Quantum-Si incorporated | -91.8 Million USD | -3476.097% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 560.831% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 2696.18% |
| SciSparc Ltd. | -5.28 Million USD | -62054.487% |
| Vericel Corporation | 2.86 Million USD | 114729.888% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -3448139.644% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -15035.01% |
| Generation Bio Co. | -133.3 Million USD | -2362.866% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -3853.993% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -3716.421% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -1343.496% |
| Invivyd, Inc. | -196.61 Million USD | -1569.761% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -777.449% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -35296.997% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 12190.3% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -31820.272% |
| 2seventy bio, Inc. | -206.41 Million USD | -1490.462% |
| ADMA Biologics, Inc. | 5.12 Million USD | 64221.094% |
| Clene Inc. | -43.24 Million USD | -7492.331% |
| Capricor Therapeutics, Inc. | -23 Million USD | -14168.344% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -6672.284% |
| GeoVax Labs, Inc. | -26.66 Million USD | -12210.279% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -995.919% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -8838.356% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 14026.95% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 66960.071% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -10007.136% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -1972.549% |
| Vir Biotechnology, Inc. | -684.3 Million USD | -379.757% |
| Evaxion Biotech A/S | -21.4 Million USD | -15238.971% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -4843.16% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -1408.253% |
| Trevena, Inc. | -35.28 Million USD | -9203.446% |
| Surrozen, Inc. | -41.13 Million USD | -7881.814% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -4024.786% |
| Cingulate Inc. | -22.95 Million USD | -14203.745% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -43902.144% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -8705.622% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -39808.241% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -3110.256% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -4740.255% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -5524.272% |
| Clearmind Medicine Inc. | -8.71 Million USD | -37589.441% |
| Kronos Bio, Inc. | -121.83 Million USD | -2594.739% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -4316.077% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -134371.253% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -3156.072% |
| Statera Biopharma, Inc. | 38.93 Million USD | 8532.012% |
| ImmunityBio, Inc. | -436.18 Million USD | -652.667% |
| Korro Bio, Inc. | -80.9 Million USD | -3957.896% |
| Kineta, Inc. | -15.71 Million USD | -20792.198% |
| BioVie Inc. | -31.95 Million USD | -10175.363% |
| Codexis, Inc. | -49.28 Million USD | -6561.526% |
| Celularity Inc. | -183.94 Million USD | -1684.763% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -1382.1% |
| Celcuity Inc. | -58.3 Million USD | -5530.256% |
| Virax Biolabs Group Limited | -6.6 Million USD | -49573.604% |
| Cibus, Inc. | -314.58 Million USD | -943.597% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -9632.31% |
| IN8bio, Inc. | -28.5 Million USD | -11417.682% |
| Kodiak Sciences Inc. | -259.02 Million USD | -1167.455% |
| Annexon, Inc. | -141.57 Million USD | -2218.912% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -2815.656% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -5014.026% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -11643.874% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -1327.329% |
| Eyenovia, Inc. | -24.1 Million USD | -13518.996% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 7430.743% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -1013171.605% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -4348.268% |
| Arcellx, Inc. | -64.14 Million USD | -5018.092% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -7193.287% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -2558.816% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -10530.788% |
| Moolec Science SA | -52.07 Million USD | -6204.304% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -6261.663% |
| Geron Corporation | -174.78 Million USD | -1778.34% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -8022.82% |
| Royalty Pharma plc | 1.88 Billion USD | 273.955% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -2645.144% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -35109.251% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -15728.739% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -1876.758% |
| Humacyte, Inc. | -96.45 Million USD | -3303.554% |
| Structure Therapeutics Inc. | -102.45 Million USD | -3104.209% |
| 89bio, Inc. | -134.46 Million USD | -2341.564% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -4062.282% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 81121.718% |
| Genelux Corporation | -24.16 Million USD | -13485.765% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -9613.018% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -1908.393% |
| Notable Labs, Ltd. | -14.4 Million USD | -22698.611% |
| Liquidia Corporation | -70.05 Million USD | -4586.585% |
| Mustang Bio, Inc. | -48.06 Million USD | -6730.618% |
| Immunovant, Inc. | -269.97 Million USD | -1116.025% |
| Quantum-Si incorporated | -91.8 Million USD | -3476.097% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -4524.856% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -16903.315% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -3118.249% |
| Acasti Pharma Inc. | -11.3 Million USD | -28950.527% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -14652.907% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -21314.258% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -1459.524% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -76779.07% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -20573.804% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -11308.813% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -8765.784% |
| PepGen Inc. | -83.58 Million USD | -3827.879% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -11027.305% |
| United Therapeutics Corporation | 1.38 Billion USD | 336.732% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -14238.123% |
| Solid Biosciences Inc. | -93.43 Million USD | -3413.71% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -68700.956% |
| Immuneering Corporation | -58.06 Million USD | -5554.417% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 102369916.027% |
| Silo Pharma, Inc. | -3.62 Million USD | -90435.197% |
| Belite Bio, Inc | -31.52 Million USD | -10312.636% |
| XOMA Corporation | -39.36 Million USD | -8240.531% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -4767.526% |
| Bionomics Limited | -9.83 Million USD | -33274.013% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -3809.031% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -9386.794% |
| uniQure N.V. | -253.1 Million USD | -1197.116% |
| Cassava Sciences, Inc. | -95.68 Million USD | -3330.978% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -44810.479% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -2435.057% |
| Forte Biosciences, Inc. | -32.47 Million USD | -10008.693% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -40680.213% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -11534.005% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -1013171.605% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -29367.732% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -20546.5% |
| Altimmune, Inc. | -87.93 Million USD | -3633.439% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -3465.417% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -9386.794% |
| Compugen Ltd. | -12.51 Million USD | -26130.425% |
| Peak Bio, Inc. | -1356.23 USD | -242067985.797% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -6655.422% |
| Benitec Biopharma Inc. | -22.49 Million USD | -14497.599% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -1254.915% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -11401.944% |
| Zura Bio Limited | -60.56 Million USD | -5320.801% |
| PolyPid Ltd. | -20.26 Million USD | -16101.944% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -20927.349% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -11401.944% |
| Instil Bio, Inc. | -146.12 Million USD | -2146.753% |
| argenx SE | -216.02 Million USD | -1419.745% |
| Immunome, Inc. | -28.27 Million USD | -11512.607% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -6672.843% |
| Verona Pharma plc | -52.46 Million USD | -6157.197% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -3364.103% |
| Shattuck Labs, Inc. | -87.61 Million USD | -3647.075% |
| CervoMed Inc. | -2.17 Million USD | -151059.782% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -2585.612% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -25764.65% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -6714.879% |
| Moolec Science SA | -52.07 Million USD | -6204.304% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -19054.044% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -2417.811% |
| AnaptysBio, Inc. | -143.16 Million USD | -2193.174% |
| Design Therapeutics, Inc. | -66.32 Million USD | -4849.868% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -3953.737% |
| NeurAxis, Inc. | -6.66 Million USD | -49161.047% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -8596.689% |
| Lumos Pharma, Inc. | -36.57 Million USD | -8877.304% |
| Achilles Therapeutics plc | -70.44 Million USD | -4560.572% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -3364.103% |
| 180 Life Sciences Corp. | -22.13 Million USD | -14732.366% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 56419.453% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -134371.253% |
| Nutriband Inc. | -5.12 Million USD | -63998.847% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -2891.398% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -5822.572% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -6394.56% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -4929.337% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -5967.277% |
| Palisade Bio, Inc. | -12.28 Million USD | -26632.351% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -7135.102% |
| Beam Therapeutics Inc. | -156.47 Million USD | -1998.126% |
| Neurogene Inc. | -52.28 Million USD | -6178.927% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -2305.304% |
| AEON Biopharma, Inc. | -48.36 Million USD | -6688.528% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -3429.424% |
| Sesen Bio, Inc. | -50.84 Million USD | -6357.514% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -3906.981% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -26482.946% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -668.075% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -3020.811% |
| Athira Pharma, Inc. | -116.7 Million USD | -2713.124% |
| Vaccinex, Inc. | -19.74 Million USD | -16524.468% |
| HCW Biologics Inc. | -23.57 Million USD | -13825.145% |
| XOMA Corporation | -39.36 Million USD | -8240.531% |
| Nektar Therapeutics | -243.1 Million USD | -1250.434% |
| Arvinas, Inc. | -394.8 Million USD | -731.56% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 1739843.304% |
| Merus N.V. | -149.2 Million USD | -2100.299% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -3411.606% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -10402.239% |
| Rezolute, Inc. | -68.42 Million USD | -4698.094% |
| Clene Inc. | -43.24 Million USD | -7492.331% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -21187.508% |
| BeyondSpring Inc. | -21.54 Million USD | -15141.411% |
| Synlogic, Inc. | -55.16 Million USD | -5851.669% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -27070.405% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -30749.464% |
| Peak Bio, Inc. | -1356.23 USD | -242067985.797% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -10012.429% |
| Krystal Biotech, Inc. | 17.9 Million USD | 18436.685% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -2672.266% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -861.781% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -71169.911% |
| MannKind Corporation | 15.12 Million USD | 21800.046% |
| Ikena Oncology, Inc. | -74.39 Million USD | -4312.812% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -25970.039% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 16250.932% |
| Gossamer Bio, Inc. | -172.15 Million USD | -1807.036% |
| CohBar, Inc. | -12.06 Million USD | -27109.229% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -12769.967% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -10834.221% |
| Legend Biotech Corporation | -477.87 Million USD | -587.003% |
| Mural Oncology plc | -192.72 Million USD | -1603.508% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -2778.461% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -20234.129% |
| Disc Medicine, Inc. | -91.02 Million USD | -3506.701% |
| Champions Oncology, Inc. | -5.05 Million USD | -64858.449% |
| REGENXBIO Inc. | -239.46 Million USD | -1270.979% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -30530.18% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -5788.156% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -8368.266% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -2810.306% |
| Vaxart, Inc. | -74.72 Million USD | -4293.56% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -9224.507% |
| Cellectis S.A. | -98.09 Million USD | -3246.756% |
| Longeveron Inc. | -20.06 Million USD | -16265.902% |
| Repare Therapeutics Inc. | -114.27 Million USD | -2772.945% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -647.502% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -4288.333% |
| Revolution Medicines, Inc. | -430.58 Million USD | -662.456% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -52102.258% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -10562.899% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -4301.394% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 67059.005% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -29840.72% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 171.289% |
| Denali Therapeutics Inc. | -179.97 Million USD | -1724.163% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -3448139.644% |
| Veru Inc. | -89.97 Million USD | -3548.768% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -12114.45% |
| Cingulate Inc. | -22.95 Million USD | -14203.745% |
| Passage Bio, Inc. | -98.34 Million USD | -3238.384% |
| Context Therapeutics Inc. | -25.06 Million USD | -13000.26% |
| Exicure, Inc. | -15.53 Million USD | -21027.486% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -1493.194% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -8778.732% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -54959.91% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -1848.784% |
| Nuvalent, Inc. | -149.49 Million USD | -2096.104% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -40269.312% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -3722.153% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -10778.786% |
| OmniAb, Inc. | -49.73 Million USD | -6501.516% |
| Anew Medical, Inc. | -1.3 Million USD | -252275.388% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -26452.896% |
| Lipocine Inc. | -16.32 Million USD | -20013.136% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -4824.254% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -4318.395% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -8509.292% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -8314.928% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -14699.621% |
| Sage Therapeutics, Inc. | -545.07 Million USD | -502.308% |
| Ocugen, Inc. | -64.82 Million USD | -4964.248% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -3446.505% |
| Q32 Bio Inc. | -86.5 Million USD | -3695.288% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -19295.049% |
| Alumis Inc. Common Stock | -156.89 Million USD | -1992.549% |
| Equillium, Inc. | -12.13 Million USD | -26947.29% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -5514.653% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -41439.352% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -17306.312% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -6931.183% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -2987.122% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -18254.533% |
| Dominari Holdings Inc. | -22.44 Million USD | -14530.125% |
| Edesa Biotech, Inc. | -8.19 Million USD | -39984.775% |
| vTv Therapeutics Inc. | -25.41 Million USD | -12819.093% |
| Bio-Techne Corporation | 326.66 Million USD | 1105.011% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -753.029% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 1617.175% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -2404.042% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -8670.805% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -2072.719% |
| Nkarta, Inc. | -120.48 Million USD | -2624.911% |
| BioCardia, Inc. | -11.56 Million USD | -28299.654% |
| Iterum Therapeutics plc | -34.58 Million USD | -9393.927% |